Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of this trial is to demonstrate the efficacy and safety of dabigatran
etexilate in patients with non-valvular atrial fibrillation for the prevention of stroke and
systemic embolism.
Phase:
Phase 3
Details
Lead Sponsor:
Boehringer Ingelheim
Collaborators:
Population Health Research Institute Uppsala University